Janney Montgomery Scott LLC purchased a new position in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 24,919 shares of the health services provider's stock, valued at approximately $416,000.
Other institutional investors also recently made changes to their positions in the company. Smartleaf Asset Management LLC boosted its position in Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after acquiring an additional 1,473 shares during the period. Covestor Ltd grew its holdings in Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock valued at $93,000 after buying an additional 1,244 shares during the last quarter. GAMMA Investing LLC grew its holdings in Select Medical by 217.4% in the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock valued at $109,000 after buying an additional 4,453 shares during the last quarter. Lazard Asset Management LLC lifted its position in shares of Select Medical by 47.8% in the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock worth $130,000 after acquiring an additional 2,255 shares during the period. Finally, Quarry LP lifted its position in shares of Select Medical by 963.0% in the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider's stock worth $171,000 after acquiring an additional 8,224 shares during the period. 89.48% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Select Medical news, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the sale, the chief executive officer owned 714,516 shares of the company's stock, valued at approximately $12,861,288. The trade was a 23.95% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Parvinderjit S. Khanuja acquired 21,000 shares of the firm's stock in a transaction dated Monday, May 5th. The stock was bought at an average cost of $15.02 per share, with a total value of $315,420.00. Following the acquisition, the director owned 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. 11.60% of the stock is currently owned by insiders.
Select Medical Price Performance
Shares of SEM traded up $0.15 during mid-day trading on Friday, reaching $15.28. 378,267 shares of the stock traded hands, compared to its average volume of 980,642. The firm has a fifty day moving average price of $15.28 and a 200 day moving average price of $17.07. The company has a market cap of $1.96 billion, a price-to-earnings ratio of 11.40, a price-to-earnings-growth ratio of 0.80 and a beta of 1.32. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.87. Select Medical Holdings Corporation has a 1 year low of $14.03 and a 1 year high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last announced its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a return on equity of 11.04% and a net margin of 2.81%. The firm's revenue was down 24.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.75 earnings per share. As a group, equities research analysts predict that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.
Select Medical announced that its Board of Directors has initiated a stock repurchase plan on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's management believes its shares are undervalued.
Select Medical Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date was Thursday, May 15th. Select Medical's dividend payout ratio (DPR) is presently 18.66%.
Analyst Upgrades and Downgrades
Several research firms have recently commented on SEM. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price for the company. Royal Bank Of Canada cut their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a report on Wednesday, May 7th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Select Medical presently has a consensus rating of "Moderate Buy" and a consensus target price of $26.00.
Get Our Latest Stock Analysis on SEM
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.